Pulmonary Arterial Hypertension Market,Growth and Price Analysis and Forecast 2016


Posted May 13, 2016 by sankmalu

The report provides comprehensive information on the therapeutics under development for Pulmonary Arterial Hypertension, complete with analysis by stage of development, drug target.

 
Pulmonary Arterial Hypertension Market Share, Size, Defination, Treatment, Causes, Syndrome, Pipeline Review, H1 2016

The report provides comprehensive information on the therapeutics under development for Pulmonary Arterial Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Arterial Hypertension and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information.

Browse Detail Report With TOC @ http://www.radiantinsights.com/research/pulmonary-arterial-hypertension-pipeline-review-h1-2016

Reasons to Buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Pulmonary Arterial Hypertension

Table of Content

Table of Contents 2
List of Tables 6

Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports

List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Pulmonary Arterial Hypertension Overview 9
Therapeutics Development 10
Pipeline Products for Pulmonary Arterial Hypertension - Overview 10
Pipeline Products for Pulmonary Arterial Hypertension - Comparative Analysis 11
Pulmonary Arterial Hypertension - Therapeutics under Development by Companies 12
Pulmonary Arterial Hypertension - Therapeutics under Investigation by Universities/Institutes 16
Pulmonary Arterial Hypertension - Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19

Browse Full Report @ http://www.radiantinsights.com/research/pulmonary-arterial-hypertension-pipeline-review-h1-2016

About Us:

Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:

Michelle Thoras
Corporate Sales Specialist, USA

Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Radiant Insights
Website Pulmonary Arterial Hypertension - Pipeline Review, H1 2016
Phone 1-415-349-0054
Business Address Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc 28 2nd Street, Suite 3036 San Francisco, CA 94105 United States
Country United States
Categories Health , Science
Tags 2016 pulmonary arterial hypertension h1 market causes , pulmonary arterial hypertension h1 market size , pulmonary arterial hypertension h1 market treatment
Last Updated May 13, 2016